SV2002000474A - HYGROMYCIN DERIVATIVES TO REF.PC11O32ABCZ / BB - Google Patents
HYGROMYCIN DERIVATIVES TO REF.PC11O32ABCZ / BBInfo
- Publication number
- SV2002000474A SV2002000474A SV2001000474A SV2001000474A SV2002000474A SV 2002000474 A SV2002000474 A SV 2002000474A SV 2001000474 A SV2001000474 A SV 2001000474A SV 2001000474 A SV2001000474 A SV 2001000474A SV 2002000474 A SV2002000474 A SV 2002000474A
- Authority
- SV
- El Salvador
- Prior art keywords
- compounds
- formula
- infections
- ref
- refers
- Prior art date
Links
- YQYJSBFKSSDGFO-UHFFFAOYSA-N Epihygromycin Natural products OC1C(O)C(C(=O)C)OC1OC(C(=C1)O)=CC=C1C=C(C)C(=O)NC1C(O)C(O)C2OCOC2C1O YQYJSBFKSSDGFO-UHFFFAOYSA-N 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 4
- 208000015181 infectious disease Diseases 0.000 abstract 2
- 208000035143 Bacterial infection Diseases 0.000 abstract 1
- 230000000844 anti-bacterial effect Effects 0.000 abstract 1
- 230000001580 bacterial effect Effects 0.000 abstract 1
- 208000022362 bacterial infectious disease Diseases 0.000 abstract 1
- 239000003795 chemical substances by application Substances 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 239000012453 solvate Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
- C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
- C07D407/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
- C07D407/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D453/00—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
- C07D453/02—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/08—Bridged systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
- C07H15/20—Carbocyclic rings
- C07H15/203—Monocyclic carbocyclic rings other than cyclohexane rings; Bicyclic carbocyclic ring systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Genetics & Genomics (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Molecular Biology (AREA)
- Public Health (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biotechnology (AREA)
- Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Tropical Medicine & Parasitology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
ESTA INVENCION SE REFIERE A COMPUESTOS DE FORMULA, Y A SALES, PROFARMACOS Y SOLVATOS FARMACEUTICAMENTE ACEPTABLES DE LOS MISMOS, EN LA QUE R1, R2, R3 Y R10 SON COMO SE HAN DEFINIDO EN ESTE DOCUMENTO. LOS COMPUESTOS DE FORMULA 1 SON AGENTES ANTIBACTERIANOS Y ANTIPROTOZOARIOS QUE PUEDEN USARSE PARA TRATAR DIVERSAS INFECCIONES BACTERIANAS Y PROTOZOARIAS Y TRASTORNOS RELACIONADOS CON TALES INFECCIONES. LA INVENCION TAMBIEN SE REFIERE A COMPOSICIONES FARMACEUTICAS QUE CONTIENEN LOS COMPUESTOS DE FORMULA 1 Y A PROCEDIMIENTOS DE TRATAMIENTO DE INFECCIONES BACTERIANAS Y PROTOZOARIAS MEDIANTE LA ADMINISTRACION DE LOS COMPUESTOS DE FORMULA 1.THIS INVENTION REFERS TO FORMULA COMPOUNDS, AND PHARMACEUTICALLY ACCEPTABLE SALTS, PROFARMACOS AND SOLVATES OF THE SAME, IN WHICH R1, R2, R3 AND R10 ARE AS DEFINED IN THIS DOCUMENT. FORMULA 1 COMPOUNDS ARE ANTIBACTERIAL AND ANTIPROTOZOAR AGENTS THAT CAN BE USED TO TREAT DIFFERENT BACTERIAL AND PROTOZOARY INFECTIONS AND DISORDERS RELATED TO SUCH INFECTIONS. THE INVENTION ALSO REFERS TO PHARMACEUTICAL COMPOSITIONS CONTAINING THE FORMULA 1 COMPOUNDS AND PROCEDURES FOR TREATMENT OF BACTERIAL INFECTIONS AND PROTOZOES THROUGH THE ADMINISTRATION OF FORMULA 1 COMPOUNDS.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US20902300P | 2000-06-02 | 2000-06-02 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SV2002000474A true SV2002000474A (en) | 2002-07-03 |
Family
ID=22777009
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SV2001000474A SV2002000474A (en) | 2000-06-02 | 2001-06-01 | HYGROMYCIN DERIVATIVES TO REF.PC11O32ABCZ / BB |
Country Status (31)
| Country | Link |
|---|---|
| US (1) | US6867230B2 (en) |
| EP (1) | EP1287011A1 (en) |
| JP (1) | JP2003535100A (en) |
| KR (1) | KR20030010655A (en) |
| CN (1) | CN1432019A (en) |
| AP (1) | AP2002002669A0 (en) |
| AR (1) | AR028667A1 (en) |
| AU (1) | AU2001260528A1 (en) |
| BG (1) | BG107265A (en) |
| BR (1) | BR0111242A (en) |
| CA (1) | CA2410643A1 (en) |
| CZ (1) | CZ20023859A3 (en) |
| EA (1) | EA200201167A1 (en) |
| EC (1) | ECSP014093A (en) |
| EE (1) | EE200200671A (en) |
| GT (1) | GT200100099A (en) |
| HU (1) | HUP0302263A2 (en) |
| IL (1) | IL152984A0 (en) |
| IS (1) | IS6618A (en) |
| MA (1) | MA26909A1 (en) |
| MX (1) | MXPA02011966A (en) |
| NO (1) | NO20025704L (en) |
| OA (1) | OA12277A (en) |
| PA (1) | PA8518101A1 (en) |
| PE (1) | PE20020334A1 (en) |
| PL (1) | PL359179A1 (en) |
| SK (1) | SK16612002A3 (en) |
| SV (1) | SV2002000474A (en) |
| TN (1) | TNSN01080A1 (en) |
| UY (1) | UY26741A1 (en) |
| WO (1) | WO2001092280A1 (en) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2486055C (en) * | 2002-05-16 | 2012-03-06 | Sepracor, Inc. | Amines that inhibit a mammalian anandamide transporter, and methods of use thereof |
| US20210275559A1 (en) * | 2018-08-20 | 2021-09-09 | Kim Lewis | Hygromycin a compounds and methods of treating spirochete diseases |
| CU20180159A7 (en) * | 2018-12-28 | 2020-10-20 | Chengdu Olisynn Biotechnology Co Ltd | DERIVATIVES OF SYNTHETIC OLIGOSACCHARIDS AS VACCINE AGAINST BORDETELLA PERTUSSIS |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US1234567A (en) * | 1915-09-14 | 1917-07-24 | Edward J Quigley | Soft collar. |
| US2004123A (en) * | 1934-02-15 | 1935-06-11 | Jr Robert B Loibl | Pest exterminator |
| CA2331261C (en) * | 1998-05-04 | 2004-07-27 | Pfizer Products Inc. | 2"-deoxy hygromycin derivatives |
| IL139165A0 (en) * | 1998-05-04 | 2001-11-25 | Pfizer Prod Inc | Hygromycin a derivatives |
| CA2352332C (en) * | 1998-12-02 | 2004-12-07 | Pfizer Products Inc. | Hygromycin a derivatives |
| KR20020063885A (en) * | 1999-10-29 | 2002-08-05 | 화이자 프로덕츠 인코포레이티드 | Hygromycin derivatives |
| US7654321B2 (en) * | 2006-12-27 | 2010-02-02 | Schlumberger Technology Corporation | Formation fluid sampling apparatus and methods |
-
2001
- 2001-05-25 CA CA002410643A patent/CA2410643A1/en not_active Abandoned
- 2001-05-25 HU HU0302263A patent/HUP0302263A2/en unknown
- 2001-05-25 AP APAP/P/2002/002669A patent/AP2002002669A0/en unknown
- 2001-05-25 PL PL01359179A patent/PL359179A1/en not_active Application Discontinuation
- 2001-05-25 CN CN01810623A patent/CN1432019A/en active Pending
- 2001-05-25 BR BR0111242-2A patent/BR0111242A/en not_active IP Right Cessation
- 2001-05-25 AU AU2001260528A patent/AU2001260528A1/en not_active Abandoned
- 2001-05-25 IL IL15298401A patent/IL152984A0/en unknown
- 2001-05-25 EP EP01934231A patent/EP1287011A1/en not_active Withdrawn
- 2001-05-25 JP JP2002500893A patent/JP2003535100A/en not_active Withdrawn
- 2001-05-25 WO PCT/IB2001/000946 patent/WO2001092280A1/en not_active Application Discontinuation
- 2001-05-25 EE EEP200200671A patent/EE200200671A/en unknown
- 2001-05-25 CZ CZ20023859A patent/CZ20023859A3/en unknown
- 2001-05-25 EA EA200201167A patent/EA200201167A1/en unknown
- 2001-05-25 SK SK1661-2002A patent/SK16612002A3/en unknown
- 2001-05-25 KR KR1020027016396A patent/KR20030010655A/en not_active Application Discontinuation
- 2001-05-25 OA OA1200200361A patent/OA12277A/en unknown
- 2001-05-25 MX MXPA02011966A patent/MXPA02011966A/en not_active Application Discontinuation
- 2001-05-30 GT GT200100099A patent/GT200100099A/en unknown
- 2001-05-30 PA PA20018518101A patent/PA8518101A1/en unknown
- 2001-05-31 UY UY26741A patent/UY26741A1/en not_active Application Discontinuation
- 2001-06-01 US US09/872,731 patent/US6867230B2/en not_active Expired - Fee Related
- 2001-06-01 EC EC2001004093A patent/ECSP014093A/en unknown
- 2001-06-01 PE PE2001000511A patent/PE20020334A1/en not_active Application Discontinuation
- 2001-06-01 SV SV2001000474A patent/SV2002000474A/en not_active Application Discontinuation
- 2001-06-01 TN TNTNSN01080A patent/TNSN01080A1/en unknown
- 2001-06-01 AR ARP010102642A patent/AR028667A1/en unknown
-
2002
- 2002-11-12 BG BG107265A patent/BG107265A/en unknown
- 2002-11-14 IS IS6618A patent/IS6618A/en unknown
- 2002-11-27 NO NO20025704A patent/NO20025704L/en not_active Application Discontinuation
- 2002-11-29 MA MA26928A patent/MA26909A1/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| NO20025704D0 (en) | 2002-11-27 |
| BR0111242A (en) | 2003-06-03 |
| SK16612002A3 (en) | 2004-04-06 |
| EA200201167A1 (en) | 2003-06-26 |
| CZ20023859A3 (en) | 2004-02-18 |
| GT200100099A (en) | 2002-01-31 |
| PE20020334A1 (en) | 2002-04-30 |
| OA12277A (en) | 2006-05-11 |
| HUP0302263A2 (en) | 2003-10-28 |
| BG107265A (en) | 2003-07-31 |
| IL152984A0 (en) | 2003-06-24 |
| US6867230B2 (en) | 2005-03-15 |
| CN1432019A (en) | 2003-07-23 |
| NO20025704L (en) | 2002-11-27 |
| PA8518101A1 (en) | 2002-09-17 |
| AR028667A1 (en) | 2003-05-21 |
| AP2002002669A0 (en) | 2002-12-31 |
| UY26741A1 (en) | 2001-12-28 |
| PL359179A1 (en) | 2004-08-23 |
| CA2410643A1 (en) | 2001-12-06 |
| EE200200671A (en) | 2004-08-16 |
| KR20030010655A (en) | 2003-02-05 |
| US20030045528A1 (en) | 2003-03-06 |
| AU2001260528A1 (en) | 2001-12-11 |
| EP1287011A1 (en) | 2003-03-05 |
| TNSN01080A1 (en) | 2005-11-10 |
| IS6618A (en) | 2002-11-14 |
| WO2001092280A1 (en) | 2001-12-06 |
| ECSP014093A (en) | 2002-01-25 |
| JP2003535100A (en) | 2003-11-25 |
| MA26909A1 (en) | 2004-12-20 |
| MXPA02011966A (en) | 2003-04-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PA8486001A1 (en) | CELECOXIB COMPOSITIONS | |
| PA8472301A1 (en) | ISOTIAZOLE DERIVATIVES USEFUL AS ANTI-CANCER AGENTS | |
| PA8489501A1 (en) | CETOLID ANTIBIOTICS | |
| BG106586A (en) | Pyrazolopyramidines as therapeutic agents | |
| BG108269A (en) | Pyrazolopyrimidines as therapeutic agents | |
| BG108268A (en) | Pyrazolopyrimidines as therapeutic agents | |
| PA8480101A1 (en) | DERIVATIVES OF QUINOLIN-2-ONA ALQUINILS SUBSTITUTED USEFUL AS ANTI-TARGET AGENTS | |
| CO4930259A1 (en) | DERIVATIVES 6,6-HETEROBICICLICOS SUBSTITUTED AND PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM | |
| UY25780A1 (en) | NEW MACROLID ANTIBIOTICS | |
| BR0010938A (en) | 13-Methyl erythromycin derivatives | |
| PA8485601A1 (en) | AZALIDAS OF 13 MEMBERS AND THEIR USE AS ANTIBIOTIC AGENTS. | |
| PA8568101A1 (en) | INDOLIL-UREA DERIVED FROM USEFUL TIENOPIRIDINS AS ANTIANGIOGEN AGENTS, AND PROCEDURES FOR USE | |
| DE60102171D1 (en) | Ketolidantibiotika | |
| PA8487701A1 (en) | DERIVATIVES OF 3,3-BIARYLIPIPERIDINE AND 2,2-BIARYLMORPHOLINE | |
| CO4810376A1 (en) | TRICYCLIC ERYTHROMYCINE DERIVATIVES | |
| PA8471801A1 (en) | HYGROMYCIN A DERIVATIVES | |
| MXPA05010783A (en) | Antimicrobial [3.1.0] bicyclohexylphenyl-oxazolidinone derivatives and analogues. | |
| SV2002000474A (en) | HYGROMYCIN DERIVATIVES TO REF.PC11O32ABCZ / BB | |
| PA8471901A1 (en) | 2 "-DESOXY HYGROMYCIN DERIVATIVES | |
| PA8545601A1 (en) | 4-AMINOPIRIMIDINE DERIVATIVES | |
| PT1167376E (en) | MACROLIDOS ANTIBIOTICS | |
| PA8450901A1 (en) | Erythromycin derivatives | |
| PA8474401A1 (en) | 3-KETO TRICYCLIC DERIVATIVES OF 6-0-METHYLERITHROMYCIN | |
| PA8505801A1 (en) | HYGROMYCIN DERIVATIVES | |
| AR019784A1 (en) | HYGROMYCIN DERIVATIVES |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FD | Lapse |